Is 20 mg IV Solumedrol (methylprednisolone) too much for an 18 kg male with asthma exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, 20 mg IV Solumedrol (methylprednisolone) is not too much for an 18 kg male with asthma exacerbation. This dose is appropriate and within the recommended range for pediatric patients experiencing asthma exacerbations. The typical dosing for IV methylprednisolone in pediatric asthma exacerbations ranges from 1-2 mg/kg/day, with a maximum of 60-80 mg per day 1. For an 18 kg child, this would allow for approximately 18-36 mg per day, making the 20 mg dose well within safe parameters. Methylprednisolone works by reducing inflammation in the airways, decreasing mucus production, and helping to relax bronchial smooth muscles. When administering this medication, monitor the patient for improvement in respiratory status, including decreased wheezing, improved oxygen saturation, and reduced work of breathing. Also watch for potential side effects such as increased heart rate, tremors, or agitation. The IV route is appropriate during acute exacerbations as it provides faster onset of action compared to oral corticosteroids. Once the patient shows improvement, consider transitioning to oral prednisolone or prednisone to complete a 3-5 day course of steroids, as there is no need to taper the dose for courses less than 1 week 1. Key considerations in managing asthma exacerbations include:

  • Prompt evaluation and treatment
  • Administration of oxygen, inhaled β2-agonists, and systemic corticosteroids
  • Monitoring of lung function and adjustment of treatment based on severity of exacerbation
  • Discharge planning with prescription of corticosteroid therapy to reduce risk of recurrence.

From the Research

Dosage of IV Solumedrol for Asthma Exacerbation

  • The dosage of 20 mg IV Solumedrol (methylprednisolone) for an 18 kg male with asthma exacerbation needs to be evaluated in the context of available evidence.
  • According to the study 2, oral prednisone at 2 mg/kg/dose (maximum 120 mg/dose) twice daily was compared with intravenous methylprednisolone at 1 mg/kg/dose (maximum 60 mg/dose) four times daily in hospitalized children with acute asthma exacerbation.
  • For an 18 kg male, the calculated dose of methylprednisolone would be approximately 18 mg (1 mg/kg/dose), which is close to the given dose of 20 mg IV Solumedrol.
  • However, it is essential to consider that the study 2 was conducted in children, and the dosage may vary for adults.

Comparison with Other Studies

  • The study 3 compared oral prednisolone with intravenous hydrocortisone in adults with acute exacerbation of bronchial asthma, but it did not provide specific dosage recommendations for methylprednisolone.
  • The study 4 used IV methylprednisolone in adults with acute severe asthma, but it did not discuss the optimal dosage for this population.
  • The study 5 focused on the use of intravenous magnesium sulfate in adults with acute asthma, and it did not provide information on the dosage of methylprednisolone.
  • The study 6 discussed the pathophysiology and treatment of severe exacerbations of asthma but did not provide specific guidance on the dosage of methylprednisolone.

Conclusion on Available Evidence

  • Based on the available evidence, it appears that the dosage of 20 mg IV Solumedrol for an 18 kg male with asthma exacerbation is relatively close to the calculated dose of methylprednisolone in the study 2.
  • However, it is crucial to consult with a healthcare professional to determine the optimal dosage and treatment plan for each individual patient, as the dosage may vary depending on the specific clinical context and patient population.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral versus intravenous corticosteroids in children hospitalized with asthma.

The Journal of allergy and clinical immunology, 1999

Research

Oral versus intravenous steroids in acute exacerbation of asthma--randomized controlled study.

The Journal of the Association of Physicians of India, 2011

Research

Severe exacerbations of asthma.

Critical care nursing quarterly, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.